@article {1417569,
	title = {Mouse model of ocular hypertension with retinal ganglion cell degeneration},
	journal = {PLoS One},
	volume = {14},
	number = {1},
	year = {2019},
	month = {2019},
	pages = {e0208713},
	abstract = {OBJECTIVES: Ocular hypertension is a primary risk factor for glaucoma and results in retinal ganglion cell (RGC) degeneration. Current animal models of glaucoma lack severe RGC cell death as seen in glaucoma, making assessment of physiological mediators of cell death difficult. We developed a modified mouse model of ocular hypertension whereby long-lasting elevation of intraocular pressure (IOP) is achieved, resulting in significant reproducible damage to RGCs. RESULTS: In this model, microbeads are mixed with hyaluronic acid and injected into the anterior chamber of C57BL/6J mice. The hyaluronic acid allows for a gradual release of microbeads, resulting in sustained blockage of Schlemm{\textquoteright}s canal. IOP elevation was bimodal during the course of the model{\textquoteright}s progression. The first peak occurred 1 hours after beads injection, with an IOP value of 44.69 {\textpm} 6.00 mmHg, and the second peak occurred 6-12 days post-induction, with an IOP value of 34.91 {\textpm} 5.21 mmHg. RGC damage was most severe in the peripheral retina, with a loss of 64.1\% compared to that of untreated eyes, while the midperiphery exhibited a 32.4\% loss, 4 weeks following disease induction. CONCLUSIONS: These results suggest that sustained IOP elevation causes more RGC damage in the periphery than in the midperiphery of the retina. This model yields significant and reproducible RGC degeneration.},
	issn = {1932-6203},
	doi = {10.1371/journal.pone.0208713},
	author = {Mukai, Ryo and Park, Dong Ho and Okunuki, Yoko and Hasegawa, Eiichi and Klokman, Garrett and Kim, Clifford B and Krishnan, Anitha and Gregory-Ksander, Meredith and Husain, Deeba and Miller, Joan W and Connor, Kip M}
}
